# Beyond Survival: Factors Driving Textbook Outcome After Simultaneous Pancreas–Kidney Transplantation—A Retrospective Analysis

**Authors:** Anke Mittelstädt, Frederik Weber, Maximilian Brunner, Christian Krautz, Florian Struller, Hendrik Apel, Bernd Wullich, Katharina Heller, Mirian Opgenoorth, Mario Schiffer, Robert Grützmann, Georg F. Weber

PMC · DOI: 10.3390/jcm15041465 · 2026-02-13

## TL;DR

This study identifies factors that influence successful outcomes after combined pancreas and kidney transplants, showing that younger donors and shorter organ transport times improve long-term survival.

## Contribution

The study identifies donor age and kidney cold ischemia time as independent predictors of textbook outcomes in SPK transplantation.

## Key findings

- 52% of SPK recipients achieved the textbook outcome benchmark.
- Donor age ≤ 37 years and kidney CIT ≤ 11.5 hours were optimal thresholds for achieving TO.
- Patients achieving TO had significantly better 15-year survival rates.

## Abstract

Background: Simultaneous pancreas–kidney transplantation (SPK) is the standard treatment for selected patients with type 1 diabetes mellitus and end-stage renal disease. Textbook Outcome (TO), a composite of perioperative and long-term quality indicators, provides a benchmark for optimal results. This study analyzed factors associated with failure to achieve TO after SPK. Methods: We retrospectively analyzed 119 SPK recipients (1980–2022). TO was defined according to IQTIG criteria: (i) patient survival ≥ 3 years, (ii) insulin independence at discharge, (iii) kidney function at discharge (GFR ≥ 20 mL/min), (iv) insulin-free survival ≥ 3 years, and (v) sustained kidney function ≥ 3 years. Predictors of TO failure were identified by logistic regression. Long-term survival was assessed by Kaplan–Meier analysis. Results: Ninety-two patients were eligible for TO assessment; 52% achieved TO. Compared with TO patients, non-TO patients had older donors (median 30 vs. 25.5 years, p = 0.017), older recipients (44 vs. 39 years, p = 0.012), longer kidney cold ischemia time (CIT; 13.0 vs. 9.7 h, p = 0.005), and more pancreatic complications (p = 0.009). In multivariate analysis, donor age (OR 1.050, p = 0.030) and kidney CIT (OR 1.180, p = 0.029) independently predicted TO failure. Cut-offs were donor age ≤ 37 years and kidney CIT ≤ 11.5 h. Patients achieving TO had significantly better long-term survival (15 years, p = 0.0077). Conclusions: Younger donor age and shorter kidney CIT independently predict TO achievement, which is associated with superior long-term survival. Optimized donor selection and perioperative management may improve SPK outcomes.

## Linked entities

- **Diseases:** type 1 diabetes mellitus (MONDO:0005147), end-stage renal disease (MONDO:0004375)

## Full-text entities

- **Genes:** HLA-A (major histocompatibility complex, class I, A) [NCBI Gene 3105] {aka HLAA}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}
- **Diseases:** CMV (MESH:D003586), SPK (MESH:D007674), bleeding (MESH:D006470), obesity (MESH:D009765), venous (MESH:D014647), T1DM (MESH:D003922), Pancreatic Complications (MESH:D010182), diabetic nephropathy (MESH:D003928), Cold Ischemia (MESH:D007511), sarcomas (MESH:D012509), neuropathy (MESH:D009422), axis calcification (MESH:C566610), injury to (MESH:D014947), reperfusion injury (MESH:D015427), thrombosis (MESH:D013927), loss (MESH:D016388), death (MESH:D003643), Pancreatic graft thrombosis (MESH:D055589), TO (MESH:D011248), Pancreas (MESH:D010190), TO failure (MESH:D051437), ESRD (MESH:D007676), diabetes (MESH:D003920), pancreatic (MESH:D010195)
- **Chemicals:** creatinine (MESH:D003404), SPK (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12942156/full.md

---
Source: https://tomesphere.com/paper/PMC12942156